Internationally acclaimed hematologist-oncologist Guido Marcucci, M.D., joins City of Hope
January 25, 2015

Physician/scientist will head Gehr Leukemia Center at new Hematology Institute

DUARTE, Calif. — Renowned physician and researcher Guido Marcucci has joined City of Hope in a key leadership role within the institution’s new Hematologic Malignancies and Stem Cell Transplantation Institute. As Director of the Gehr Family Center for Leukemia Research and as Chief of the Division of Hematopoietic Stem Cell and Leukemia Research, Marcucci will guide research into improved treatments, even cures, for leukemia and other hematologic malignancies.

Marcucci, who will also serve as a professor of Hematology & Hematopoietic Cell Transplantation, joins City of Hope from Ohio State University, where he was a professor of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, and Pharmaceutics in the Division of Hematology at the university’s Comprehensive Cancer Center.  At City of Hope, he will head one of six cornerstone centers in the institution’s recently launched hematologic institute, setting scientific priorities and guiding the development of new approaches to treating leukemia and related diseases, especially those involving hematopoietic stem cell transplantation.

“City of Hope is extremely fortunate to have a scientist and physician of Dr. Marcucci’s caliber and accomplishments as chief of our new leukemia center,” said Steven T. Rosen, provost and chief scientific officer at City of Hope. “With his guidance and vision, we will be able to develop and bring to fruition revolutionary new treatments for leukemia and other diseases. His experience in leukemia and hematopoietic stem cell transplantation in particular will help us change the future for both current and future patients.”

A respected clinician, and esteemed basic and translational scientist, Marcucci joins City of Hope as the institution embarks on a new era of growth and discovery in the treatment of blood and bone marrow diseases. A world-leader in the treatment of leukemia, lymphoma, multiple myeloma and other hematologic malignancies, City of Hope is expanding its commitment to patients with these conditions  by launching an institute focused specifically on their need for improved therapies and potential cures.

“City of Hope is known world-wide as a pioneer and leader in the treatment of leukemia and other diseases, with scientists, physicians and leaders all working together to change the future of cancer treatment,” Marcucci said. “I’m extremely pleased to join such a remarkable institution as it expands its commitment to developing new treatment approaches.”
 
At Ohio State University, Marcucci held The Charles Austin Doan Chair of Medicine in the College of Medicine, and was the associate director for Translational Research at the Cancer Center. Board-certified in internal medicine and oncology, Marcucci has received numerous grants from the National Cancer Institute for his clinical and research work into acute myeloid leukemia. He also serves on the editorial boards of several journals and has published more than 270 peer-reviewed articles and papers.

Marcucci received his medical degree from the Catholic University of Sacred Heart in Rome, Italy, and completed his internal medicine internship and residency at the State University of New York (SUNY). He completed a fellowship in medical oncology at Roswell Park Cancer Institute in Buffalo, N.Y.

Stephen J. Forman, M.D., head of the institution’s new Hematologic Institute, praised Marcucci for his clinical skills as well as his research skills. “Dr. Marcucci brings a remarkable breadth and depth of research and clinical skills to City of Hope, and we’re looking forward to working with him as we move to develop tomorrow’s treatments today,” he said.

The Gehr Family Center for Leukemia Research is supported by the Gehr Family Foundation, including Norbert Gehr, and his children, Crystal Gehr, Robert Gehr, Max Gehr and Andrew Gehr.

Contact
 
About City of Hope
City of Hope is a leading research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as a comprehensive cancer center, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the nation. City of Hope’s main hospital is located in Duarte, Calif., just northeast of Los Angeles, with community clinics in southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation and genetics.